289 related articles for article (PubMed ID: 8931235)
1. Biotech patents: the world is your oyster--or mouse--or (you name it).
Alix JE
Technol Health Care; 1996 Sep; 4(3):255-8. PubMed ID: 8931235
[TBL] [Abstract][Full Text] [Related]
2. The patenting of novel biotech products.
Webber PM
IDrugs; 2007 Jul; 10(7):459-62. PubMed ID: 17642015
[TBL] [Abstract][Full Text] [Related]
3. Patent first, ask questions later: morality and biotechnology in patent law.
Bagley MA
William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
[TBL] [Abstract][Full Text] [Related]
4. [Patents on life? No patent on life!].
van Raden L
Dtsch Tierarztl Wochenschr; 1998 Mar; 105(3):90-3. PubMed ID: 9581373
[TBL] [Abstract][Full Text] [Related]
5. European Commission rethinks biotech patents.
Mitchell P
Nat Biotechnol; 2002 Dec; 20(12):1175-6. PubMed ID: 12454654
[No Abstract] [Full Text] [Related]
6. The human use of humanoid beings: chimeras and patent law.
Rabin S
Nat Biotechnol; 2006 May; 24(5):517-9. PubMed ID: 16680130
[TBL] [Abstract][Full Text] [Related]
7. A guide to drug discovery. Protecting your inventions: the patent system.
Webber PM
Nat Rev Drug Discov; 2003 Oct; 2(10):823-30. PubMed ID: 14526385
[TBL] [Abstract][Full Text] [Related]
8. Patents, biotechnology, and hematologic pathology.
Kettelberger DM; Gambrell P; McClung G
Hematol Pathol; 1992; 6(2):99-104. PubMed ID: 1607346
[No Abstract] [Full Text] [Related]
9. Harvard mouse--eating into the European patent system?
Wickremasinghe K
Australas Biotechnol; 1992 Feb; 2(1):44-6. PubMed ID: 1368031
[No Abstract] [Full Text] [Related]
10. Patent border wars: defining the boundary between scientific discoveries and patentable inventions.
Holman CM
Trends Biotechnol; 2007 Dec; 25(12):539-43. PubMed ID: 17983675
[TBL] [Abstract][Full Text] [Related]
11. Patenting pluripotence: the next battle for stem cell intellectual property.
Vrtovec KT; Scott CT
Nat Biotechnol; 2008 Apr; 26(4):393-5. PubMed ID: 18392018
[TBL] [Abstract][Full Text] [Related]
12. Biotechs sue Columbia over fourth Axel patent.
Howard K
Nat Biotechnol; 2003 Sep; 21(9):955-6. PubMed ID: 12949538
[No Abstract] [Full Text] [Related]
13. The morality of biotech patents: differing legal obligations in Europe?
Ford R
Eur Intellect Prop Rev; 1997 Jun; 19(6):315-8. PubMed ID: 16538738
[No Abstract] [Full Text] [Related]
14. Patent reform acts ugly.
Nat Biotechnol; 2007 Nov; 25(11):1187. PubMed ID: 17989652
[TBL] [Abstract][Full Text] [Related]
15. Biotechnology patenting policy in the European Union--as exemplified by the development in Germany.
Schrell A; Bauser H; Brunner H
Adv Biochem Eng Biotechnol; 2007; 107():13-39. PubMed ID: 17522818
[TBL] [Abstract][Full Text] [Related]
16. Intellectual property in higher life forms: the patent system and controversial technologies.
Merges RP
MD Law Rev; 1988; 47(4):1051-75. PubMed ID: 16514761
[No Abstract] [Full Text] [Related]
17. "Sufficiency" for living organism inventions under the Patents Act 1990 (Cth).
Lawson C
J Law Med; 2004 Feb; 11(3):373-81. PubMed ID: 15018213
[TBL] [Abstract][Full Text] [Related]
18. US court case to define EST patentability.
Lawrence S
Nat Biotechnol; 2005 May; 23(5):513. PubMed ID: 15877055
[No Abstract] [Full Text] [Related]
19. Intellectual property protection for plant-related inventions in Europe.
Fleck B; Baldock C
Nat Rev Genet; 2003 Oct; 4(10):834-8. PubMed ID: 14526379
[TBL] [Abstract][Full Text] [Related]
20. Ownership at too high a price?
Nat Biotechnol; 2003 Sep; 21(9):953. PubMed ID: 12949537
[No Abstract] [Full Text] [Related]
[Next] [New Search]
